Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Q2 2023 Earnings Call Transcript August 9, 2023
Deciphera Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.57 EPS, expectations were $0.62.
Operator: Good morning, everyone. And welcome to the Deciphera Pharmaceuticals Second Quarter 2023 Financial Results Conference Call. Today’s call is being recorded. At this time, I would like to turn the call over to Jen Larson, Senior Vice President of Finance and Investor...
